Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients.

Fabio Fulfaro

Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients.

Discipline Chirurgiche, Oncologiche e Stomatologiche

Risultato della ricerca: Other

Lingua originale	English
Pagine	140S-
Numero di pagine	1
Stato di pubblicazione	Published - 2009

Altri file e collegamenti

OA Link

Cita questo

@conference{642a1434756c42f5b8a0466570875818,

title = "Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients.",

keywords = "cancer, chemoimmunotherapy, colon, cancer, chemoimmunotherapy, colon",

author = "Fabio Fulfaro",

year = "2009",

language = "English",

pages = "140S--",

}

TY - CONF

T1 - Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients.

AU - Fulfaro, Fabio

PY - 2009

Y1 - 2009

KW - cancer

KW - chemoimmunotherapy

KW - colon

KW - cancer

KW - chemoimmunotherapy

KW - colon

UR - http://hdl.handle.net/10447/44442

M3 - Other

SP - 140S-

ER -